Liontrust Insights: Price and value – What you pay versus what you get

By John Husselbee, Head of the Liontrust Multi-Asset team at Liontrust Asset Management

 

Growing fears about rapidly inflating bubbles in certain parts of investment markets have led to renewed focus on one of the oldest – and most fundamentally misunderstood – relationships in finance, between price and value. 

Warren Buffet’s ‘price is what you pay, value is what you get’ is a favoured quote to illuminate this and we are also reminded of the Oscar Wilde character knowing ‘the price of everything and the value of nothing’. The retort to this is the even better but less well-known, ‘a sentimentalist…is a man who sees an absurd value in everything and doesn’t know the market price of any single thing’.

When it comes to most publicly traded assets, operating without the safety net of a recommended retail price, there is a difference between what something is ‘worth’ based on its fundamentals and how much people are prepared to pay for it. This means it is possible to get bargains from time to time (think of investment trusts trading on a discount, for example) but this disconnect has also fuelled every bubble in history, from the 17th century’s tulip mania through the late 1990s’ technology bubble to the frenzied trading in assets such as Bitcoin and stocks like GameStop and Tesla in recent months.

Going right back to first investment principles, the value of an asset is determined by its fundamental properties. With equities, for example, this includes its assets and liabilities, earnings, market share, management team, and, for investors, its capacity to provide cashflows over time. There are a huge range of metrics to indicate underlying value, often combining these properties, with the most popular including price to earnings ratio, price to book and debt to equity.

Price, while encompassing those fundamental elements, is also heavily influenced by far shorter-term, sentiment-driven factors, from basic supply and demand (where current fads and fashions come into play in bidding up or pulling down prices) to market noise, whether macro, micro or simply the prevailing news headlines of the day.

Most investors understand this trade off and, for the most part, longer-term fundamental factors are reflected in valuations. But there are also times when the value/price spread becomes more than simply attributable to short-term noise and bubbles emerge, with Tesla providing a perfect case study of this.
Article Image

If you look at Tesla’s price to book ratio, it was already expensive in 2018 and 2019 at around 12 times but this ballooned last year to over 40, while rival car firm Ford, in comparison, has remained stable at around one times book value. Tesla fans may try to rationalise this with claims the company is at the vanguard of an electronic revolution in the car world, and they may be proved right. But if you just focus on the here and now, Tesla’s 700%-plus share price appreciation during 2020 looks very hard to justify: the company sold just 235,000 cars in its home market (the US) last year (versus close to two million for Ford) while its market cap expanded from $75 billion to $668 billion.

For anyone wanting to invest at these multiples, they have to question what value they are getting for their money and, for shareholders, this will ultimately be determined by how far Tesla can keep rising. We harbour serious doubts about stretched valuations across several tech companies in the US and believe recent corrections could continue through this year and beyond.

Theoretically, keeping the above factors in mind should help investors from overpaying for assets, particularly in periods of volatility and overexuberance, but as any student of markets knows, fear and greed continue to dominate decision making and even the most experienced still try to time the market. In a recent paper, behavioural finance expert Oxford Risk claims that so-called emotional investing has hit a new peak in the current economic, fiscal and market environment; on average, these ill-timed decisions cost investors around 3% in lost returns a year over the long term and this figure is rising amid the current crisis.

Emotional responses to short-term market noise typically push people into buying high and selling low and they frequently pursue investments that are familiar – companies publicised in the media, for example, and those that have recently announced large gains. According to Oxford Risk, this is because, in times of stress, investors find comfort in names they hear about regularly that seem to offer the promise of short-term returns. In financial terms, as in many other parts of life, Covid-19 has left many people highly sensitive and with a shortened emotional time horizon, which increases and explains the appeal of investments that are little more than get-rich-quick gambles.

 


Liontrust Key risks and Disclaimers


Please remember that past performance is not a guide to future performance and the value of an investment and any income generated from them can fall as well as rise and is not guaranteed, therefore you may not get back the amount originally invested and potentially risk total loss of capital.

This content should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, faxed, reproduced, divulged or distributed, in whole or in part, without the express written consent of Liontrust.

Issued by Liontrust Fund Partners LLP (2 Savoy Court, London WC2R 0EZ), authorised and regulated in the UK by the Financial Conduct Authority (FRN 518165) to undertake regulated investment business.


MeDirect Disclaimers

This information has been accurately reproduced, as received from Liontrust Fund Partners LLP. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest should always be based upon the details contained in the Prospectus and Key Investor Information Document (KIID), which may be obtained from MeDirect Bank (Malta) plc.

 

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.